Sign In
Buy BSGM
$6.10
+0 (+0%)
At Close: Dec 10, 2025
BioSig CEO Kenneth L. Londoner to Present at the Oppenheimer 31st Annual Healthcare Conference
05:30pm, Wednesday, 10'th Mar 2021
Westport, CT, March 10, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing plat
BioSig CEO Kenneth L. Londoner to Present at the 33rd Annual Virtual ROTH Conference
04:45pm, Tuesday, 09'th Mar 2021
Westport, CT, March 09, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing plat
BioSig Technologies, Inc. (NASDAQ:BSGM), has said the US Patent Office has allowed a utility patent that its majority-owned subsidiary NeuroClear Technologies, Inc. had exclusively licensed from the
BioSig Awarded U.S. Patent Claims for its NeuroClear™ Subsidiary
09:15am, Thursday, 04'th Mar 2021
Westport, CT, March 04, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal process
BioSig Technologies appoints Brenda Castrodad to lead its Human Resources department
12:11pm, Tuesday, 16'th Feb 2021
BioSig Technologies, Inc. (NASDAQ:BSGM) announced Tuesday that it has appointed Brenda Castrodad to lead its Human Resources department. The medical technology company seasoned executive noted that C
BioSig Appoints Brenda Castrodad to Lead Human Resources
08:45am, Tuesday, 16'th Feb 2021
Seasoned medtech executive to scale up the Company's organizational development upon the increase in demand for the evaluative installations of the PURE EP System™ Seasoned medtech executive to scal
BioSig Technologies says it has entered into three new evaluation agreements for its PURE EP System
10:23am, Wednesday, 10'th Feb 2021
BioSig Technologies, Inc. (NASDAQ:BSGM) said it has entered into three new evaluation agreements for the PURE EP System, its novel electrophysiology (EP) signal acquisition and analysis technology. Th
Major Medical Centers Enter into Installation Agreements for Evaluation of BioSig PURE EP™ Systems
10:00am, Wednesday, 10'th Feb 2021
New 90-day evaluation cycles enable hospitals to more rapidly assess the platform technology while also accelerating BioSig's commercial activities New 90-day evaluation cycles enable hospitals to mor
BioSig CEO Kenneth L. Londoner to Present at the Virtual Investor Conference Small and Microcap Showcase
04:30pm, Wednesday, 27'th Jan 2021
Westport, CT, Jan. 27, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platf
BioSig to Present at the 26th Annual International AF Symposium
09:32am, Friday, 15'th Jan 2021
PURE EP(tm) System to be highlighted in a Spotlight session by G. Joseph Gallinghouse, M.D., Texas Cardiac Arrhythmia Institute PURE EP(tm) System to be highlighted in a Spotlight session by G. Joseph
BioSig PURE EP System Featured in the Editorial of EP Lab Digest
09:32am, Thursday, 14'th Jan 2021
Westport, CT, Jan. 14, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processi
BioSig Deploys Vuzix M400 Smart Glasses to Offer Remote Servicing Capabilities in Compliance with COVID-19 Travel Restrictions
09:32am, Wednesday, 13'th Jan 2021
Industry-leading smart glasses technology expected to enhance the utility of BioSig's PURE EP™ System signal processing platform. Remote servicing intended to enable continued installations, upgrade
BioSig Conducts First Patient Cases with PURE EP(tm) System at Memorial Hospital of South Bend, Indiana
09:32am, Tuesday, 12'th Jan 2021
PURE EP(tm) system evaluation conducted under the leadership of Cardiologists Vinod Chauhan, M.D. and Deepak Gaba, M.D. Memorial Hospital is nationally recognized for its emphasis on innovation. PURE
BioSig CEO Kenneth L. Londoner to Present at the Sidoti Winter 2021 Investor Conference
10:00am, Wednesday, 06'th Jan 2021
Westport, CT, Jan. 06, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company developing a proprietary biomedical signal processing
BioSig's Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota
08:30am, Friday, 18'th Dec 2020
NeuroClear is set to commence experiments aimed at developing therapies for autonomic nervous system disease NeuroClear is set to commence experiments aimed at developing therapies for autonomic nervo
